+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Docetaxel"

Metastatic Prostate Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Prostate Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 240 Pages
  • Global
From
Paranasal sinus cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Paranasal sinus cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Castrate Resistant Prostrate Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Castrate Resistant Prostrate Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Testicular Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Testicular Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Non-Small Cell Lung Cancer (NSCLC) Pipeline Analysis Report - Product Thumbnail Image

Non-Small Cell Lung Cancer (NSCLC) Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
Head and Neck Cancer (HNC) Pipeline Analysis Report - Product Thumbnail Image

Head and Neck Cancer (HNC) Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Breast Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 180 Pages
  • Global
From
Head and Neck Cancer Therapeutics - A Global Market Overview - Product Thumbnail Image

Head and Neck Cancer Therapeutics - A Global Market Overview

  • Report
  • November 2024
  • 301 Pages
  • Global
From
PSMA - Targeted Therapy Pipeline Review - Product Thumbnail Image

PSMA - Targeted Therapy Pipeline Review

  • Report
  • March 2025
  • Global
From
Brazil Cancer Drugs Clinical Trials Insight 2024 - Product Thumbnail Image

Brazil Cancer Drugs Clinical Trials Insight 2024

  • Report
  • August 2024
  • 660 Pages
  • Brazil
From
From
From
Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024 - Product Thumbnail Image

Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024

  • Clinical Trials
  • February 2018
  • 225 Pages
  • Global
From
Head and Neck Cancer Therapeutics: Global Markets - Product Thumbnail Image

Head and Neck Cancer Therapeutics: Global Markets

  • Report
  • August 2022
  • 148 Pages
  • Global
From
Prostate Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Prostate Cancer Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
From
TIM-3 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

TIM-3 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Checkpoint Inhibitors - Competitive landscape, 2023 - Product Thumbnail Image

Checkpoint Inhibitors - Competitive landscape, 2023

  • Report
  • April 2023
  • 350 Pages
  • Global
From
Loading Indicator

Docetaxel is a chemotherapy drug used in the treatment of various types of cancer, including breast, ovarian, and non-small cell lung cancer. It is a semi-synthetic derivative of a natural substance found in the bark of the European yew tree. Docetaxel works by interfering with the growth of cancer cells, preventing them from dividing and spreading. It is usually administered intravenously, and is often used in combination with other drugs. Docetaxel is a widely used oncology drug, and is often prescribed as a first-line treatment for certain types of cancer. It is also used in the treatment of advanced or metastatic cancer, and is sometimes used in combination with other drugs to improve the effectiveness of treatment. Some companies in the Docetaxel market include Bristol-Myers Squibb, Pfizer, and Sanofi. Show Less Read more